vs

Side-by-side financial comparison of Dexcom (DXCM) and NCR Atleos Corp (NATL). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.2B, roughly 1.1× NCR Atleos Corp). Dexcom runs the higher net margin — 21.2% vs 7.2%, a 14.0% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 4.0%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 4.9%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

NCR Voyix Corporation, previously known as NCR Corporation and National Cash Register, is a global software, consulting and technology company providing several professional services and electronic products. It manufactured self-service kiosks, point-of-sale terminals, automated teller machines, check processing systems, and barcode scanners.

DXCM vs NATL — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.1× larger
DXCM
$1.3B
$1.2B
NATL
Growing faster (revenue YoY)
DXCM
DXCM
+17.6% gap
DXCM
21.6%
4.0%
NATL
Higher net margin
DXCM
DXCM
14.0% more per $
DXCM
21.2%
7.2%
NATL
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
4.9%
NATL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DXCM
DXCM
NATL
NATL
Revenue
$1.3B
$1.2B
Net Profit
$267.3M
$83.0M
Gross Margin
62.9%
Operating Margin
25.6%
13.5%
Net Margin
21.2%
7.2%
Revenue YoY
21.6%
4.0%
Net Profit YoY
153.6%
102.4%
EPS (diluted)
$0.67
$1.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
NATL
NATL
Q1 26
$1.3B
Q4 25
$1.3B
$1.2B
Q3 25
$1.2B
$1.1B
Q2 25
$1.2B
$1.1B
Q1 25
$1.0B
$979.0M
Q4 24
$1.1B
$1.1B
Q3 24
$994.2M
$1.1B
Q2 24
$1.0B
$1.1B
Net Profit
DXCM
DXCM
NATL
NATL
Q1 26
$267.3M
Q4 25
$267.3M
$83.0M
Q3 25
$283.8M
$26.0M
Q2 25
$179.8M
$39.0M
Q1 25
$105.4M
$14.0M
Q4 24
$151.7M
$41.0M
Q3 24
$134.6M
$21.0M
Q2 24
$143.5M
$27.0M
Gross Margin
DXCM
DXCM
NATL
NATL
Q1 26
62.9%
Q4 25
62.9%
Q3 25
60.5%
Q2 25
59.5%
Q1 25
56.9%
Q4 24
58.9%
Q3 24
59.7%
Q2 24
62.4%
Operating Margin
DXCM
DXCM
NATL
NATL
Q1 26
25.6%
Q4 25
25.6%
13.5%
Q3 25
20.1%
9.8%
Q2 25
18.4%
10.8%
Q1 25
12.9%
9.5%
Q4 24
17.0%
13.4%
Q3 24
15.3%
10.6%
Q2 24
15.7%
9.8%
Net Margin
DXCM
DXCM
NATL
NATL
Q1 26
21.2%
Q4 25
21.2%
7.2%
Q3 25
23.5%
2.3%
Q2 25
15.5%
3.5%
Q1 25
10.2%
1.4%
Q4 24
13.6%
3.7%
Q3 24
13.5%
2.0%
Q2 24
14.3%
2.5%
EPS (diluted)
DXCM
DXCM
NATL
NATL
Q1 26
$0.67
Q4 25
$0.67
$1.09
Q3 25
$0.70
$0.34
Q2 25
$0.45
$0.52
Q1 25
$0.27
$0.19
Q4 24
$0.37
$0.56
Q3 24
$0.34
$0.28
Q2 24
$0.35
$0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
NATL
NATL
Cash + ST InvestmentsLiquidity on hand
$917.7M
$456.0M
Total DebtLower is stronger
$2.7B
Stockholders' EquityBook value
$2.7B
$403.0M
Total Assets
$6.3B
$5.7B
Debt / EquityLower = less leverage
6.63×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
NATL
NATL
Q1 26
$917.7M
Q4 25
$917.7M
$456.0M
Q3 25
$1.8B
$412.0M
Q2 25
$1.2B
$357.0M
Q1 25
$904.9M
$352.0M
Q4 24
$606.1M
$419.0M
Q3 24
$621.2M
$395.0M
Q2 24
$939.2M
$374.0M
Total Debt
DXCM
DXCM
NATL
NATL
Q1 26
Q4 25
$2.7B
Q3 25
$2.8B
Q2 25
$2.8B
Q1 25
Q4 24
$2.9B
Q3 24
Q2 24
Stockholders' Equity
DXCM
DXCM
NATL
NATL
Q1 26
$2.7B
Q4 25
$2.7B
$403.0M
Q3 25
$2.7B
$330.0M
Q2 25
$2.6B
$350.0M
Q1 25
$2.3B
$275.0M
Q4 24
$2.1B
$219.0M
Q3 24
$2.0B
$264.0M
Q2 24
$2.4B
$250.0M
Total Assets
DXCM
DXCM
NATL
NATL
Q1 26
$6.3B
Q4 25
$6.3B
$5.7B
Q3 25
$7.5B
$5.7B
Q2 25
$7.3B
$5.8B
Q1 25
$6.8B
$5.7B
Q4 24
$6.5B
$5.5B
Q3 24
$6.4B
$5.7B
Q2 24
$6.8B
$5.8B
Debt / Equity
DXCM
DXCM
NATL
NATL
Q1 26
Q4 25
6.63×
Q3 25
8.45×
Q2 25
8.05×
Q1 25
Q4 24
13.05×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
NATL
NATL
Operating Cash FlowLast quarter
$231.0M
Free Cash FlowOCF − Capex
$194.0M
FCF MarginFCF / Revenue
16.8%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
2.78×
TTM Free Cash FlowTrailing 4 quarters
$239.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
NATL
NATL
Q1 26
Q4 25
$294.0M
$231.0M
Q3 25
$659.9M
$25.0M
Q2 25
$303.0M
$-23.0M
Q1 25
$183.8M
$123.0M
Q4 24
$301.4M
$80.0M
Q3 24
$199.5M
$107.0M
Q2 24
$279.4M
$9.0M
Free Cash Flow
DXCM
DXCM
NATL
NATL
Q1 26
Q4 25
$192.1M
$194.0M
Q3 25
$579.4M
$-5.0M
Q2 25
$208.9M
$-44.0M
Q1 25
$96.8M
$94.0M
Q4 24
$176.8M
$62.0M
Q3 24
$88.3M
$85.0M
Q2 24
$213.3M
$-14.0M
FCF Margin
DXCM
DXCM
NATL
NATL
Q1 26
Q4 25
15.3%
16.8%
Q3 25
47.9%
-0.4%
Q2 25
18.1%
-4.0%
Q1 25
9.3%
9.6%
Q4 24
15.9%
5.6%
Q3 24
8.9%
7.9%
Q2 24
21.2%
-1.3%
Capex Intensity
DXCM
DXCM
NATL
NATL
Q1 26
Q4 25
8.1%
3.2%
Q3 25
6.7%
2.7%
Q2 25
8.1%
1.9%
Q1 25
8.4%
3.0%
Q4 24
11.2%
1.6%
Q3 24
11.2%
2.1%
Q2 24
6.6%
2.1%
Cash Conversion
DXCM
DXCM
NATL
NATL
Q1 26
Q4 25
1.10×
2.78×
Q3 25
2.33×
0.96×
Q2 25
1.69×
-0.59×
Q1 25
1.74×
8.79×
Q4 24
1.99×
1.95×
Q3 24
1.48×
5.10×
Q2 24
1.95×
0.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

NATL
NATL

Services$848.0M74%
APJ$136.0M12%
Americas Excluding United States$135.0M12%
TT$44.0M4%

Related Comparisons